Package Leaflet: Information for the User
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack and other information
Contents of the pack and additional information
Neobrufen belongs to a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs).
This medicine is used for the treatment of fever, treatment of moderate pain including migraine, treatment of arthritis (inflammation of the joints, including usually those of the hands and feet, leading to swelling and pain), juvenile rheumatoid arthritis, osteoarthritis (a chronic disorder that causes damage to the cartilage), ankylosing spondylitis (inflammation that affects the joints of the spine), non-rheumatic inflammation, and primary dysmenorrhea (painful menstruation).
Do not take Neobrufen:
Warnings and precautions
Consult your doctor or pharmacist before starting to take Neobrufen:
This risk is greater when high doses and prolonged treatments are used, in patients with a history of peptic ulcer and in elderly patients. In these cases, your doctor will consider the possibility of associating a stomach protective medication.
It is important that you use the smallest dose that relieves-controls the pain and do not take this medication for longer than necessary to control your symptoms.
With ibuprofen, signs of allergic reaction to this medication have been reported, such as respiratory problems, swelling of the face and neck area (angioedema), and chest pain. Stop using Neobrufen immediately and contact your doctor or the emergency medical service immediately if you observe any of these signs.
Precautions in elderly patients
Elderly patients have a higher frequency of adverse reactions to NSAIDs (non-steroidal anti-inflammatory drugs), especially gastrointestinal bleeding and perforation, which can be fatal.
Skin reactions
Severe skin reactions, such as exfoliative dermatitis, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS syndrome), and acute generalized exanthematous pustulosis (AGEP), have been reported in association with ibuprofen treatment. Discontinue Neobrufen treatment and seek immediate medical attention if you notice any of the symptoms related to these severe skin reactions described in section 4.
Cardiovascular precautions
Anti-inflammatory/analgesic medications like ibuprofen may be associated with a small increased risk of heart attack or stroke, especially when used in high doses. Do not exceed the recommended dose or treatment duration.
You should discuss your treatment with your doctor or pharmacist before taking Neobrufen if:
Respiratory disorders
Ibuprofen should be used with caution when administered to patients who have or have a history of bronchial asthma, chronic rhinitis, or allergic diseases, as ibuprofen has been reported to cause bronchospasm, urticaria, or angioedema in such patients.
Precautions during pregnancy and in women of childbearing age
Because the administration of medications like Neobrufen has been associated with an increased risk of congenital anomalies/abortions, it is not recommended to administer it during the first and second trimester of pregnancy unless it is strictly necessary. In these cases, the dose and duration will be limited to the minimum possible. It is believed that the risk increases with the dose and duration of treatment.
In the third trimester, the administration of Neobrufen is contraindicated.
For women of childbearing age, it should be taken into account that medications like Neobrufen have been associated with a decrease in fertility.
Infections
Neobrufen may hide the signs of an infection, such as fever and pain. Consequently, Neobrufen may delay the appropriate treatment of the infection, which can increase the risk of complications. This has been observed in bacterial pneumonia and bacterial skin infections related to chickenpox. If you take this medication while having an infection and the symptoms of the infection persist or worsen, consult your doctor without delay.
Other medications and Neobrufen
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medication.
Neobrufen may affect or be affected by other medications. For example:
Other medications may also affect or be affected by treatment with Neobrufen. Therefore, you should always consult your doctor or pharmacist before using Neobrufen with other medications.
Taking ibuprofen may alter the following laboratory tests:
Tell your doctor if you are going to undergo a clinical analysis and are taking or have recently taken ibuprofen.
Taking Neobrufen with food and drinks
It is recommended to take Neobrufen dissolved in a glass of water. You can take it alone or with food. In general, it is recommended to take it during meals or immediately after eating, to reduce the possibility of stomach discomfort. Do not drink alcohol, as it may increase gastrointestinal side effects.
Pregnancy, breastfeeding, and fertility
Consult your doctor or pharmacist before using any medication.
The use of this medication is not recommended in women who are trying to become pregnant.
Ibuprofen should not be taken during pregnancy, especially during the third trimester (see section precautions during pregnancy and in women of childbearing age), as it may harm the fetus or cause problems during delivery. It may cause kidney and heart problems in your fetus. It may affect your and your baby's tendency to bleed and delay or prolong delivery more than expected.
Do not take Neobrufen during the first 6 months of pregnancy unless it is absolutely necessary and your doctor advises you to do so. If you need treatment during this period or while trying to become pregnant, you should use the lowest dose for the shortest time necessary. From the 20th week of pregnancy onwards, Neobrufen may cause kidney problems in your fetus if taken for more than a few days, which can cause low levels of the fluid that surrounds the baby (oligohydramnios) or narrowing of the blood vessels (ductus arteriosus) in the baby's heart. If you need treatment for more than a few days, your doctor may recommend additional checks.
Although only small amounts of the medication pass into breast milk, it is recommended not to take ibuprofen for prolonged periods during breastfeeding.
If you experience dizziness, vertigo, vision disturbances, or other symptoms while taking this medication, do not drive or use hazardous machinery. If you only take one dose of Neobrufen or for a short period, it is not necessary to take special precautions.
Ibuprofen may delay your reaction time, which should be taken into account before performing activities that require greater vigilance, such as driving and using machinery.
This applies to a greater extent to the combination with alcohol.
This medication contains sucrose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Patients with diabetes mellitus should note that this medication contains 3.3 g of sucrose per sachet.
This medication contains 197 mg of sodium (the main component of table salt/cooking salt) in each sachet. This is equivalent to 9.9% of the maximum daily sodium intake recommended for an adult.
Consult your doctor or pharmacist if you need 2 or more sachets per day for a prolonged period, especially if you have been advised to follow a low-salt (sodium) diet.
Follow the administration instructions for this medication exactly as indicated by your doctor. If in doubt, consult your doctor or pharmacist again.
Your doctor will indicate the duration of treatment with Neobrufen. Do not stop treatment beforehand, as this will not achieve the expected results. Similarly, do not use this medication for longer than indicated by your doctor.
The lowest effective dose should be used for the shortest time necessary to relieve symptoms. If you have an infection, consult your doctor without delay if symptoms (such as fever and pain) persist or worsen (see section 2).
Adverse effects can be minimized by taking the lowest effective dose for the shortest time necessary to control symptoms.
Adults and adolescents over 14 years:
The recommended dose in adults and adolescents from 14 years is one sachet (600 mg) every 6 to 8 hours, depending on the intensity of the condition and response to treatment.
In some cases, higher doses may be required, but in any case, it is recommended not to exceed the maximum daily dose of 2400 mg in adults and 1600 mg in adolescents from 14 to 18 years.
Use in children and adolescents under 14 years:
The use of this medication is not recommended in children or adolescents under 14 years, as the dose of ibuprofen it contains is not suitable for the recommended dosage in these patients.
Elderly patients:
If you are over 60 years old, your doctor may prescribe a lower dose than usual. If so, the dose can only be increased once your doctor has checked that you tolerate the medication well.
Patients with kidney and/or liver disease:
If you have kidney and/or liver disease, your doctor may prescribe a lower dose than usual. If so, take the exact dose prescribed by your doctor.
If you think the effect of Neobrufen is too strong or too weak, inform your doctor or pharmacist.
Method of administration
This medication is administered orally.
To achieve a faster onset of action, the dose can be taken on an empty stomach. It is recommended that patients with sensitive stomachs take ibuprofen with food.
Make sure the ibuprofen granules are dissolved in sufficient water. You may feel a transient burning sensation in the mouth or throat when taking ibuprofen granules.
If you take more Neobrufen than you should:
If you have taken more Neobrufen than you should, or if a child has accidentally ingested the medication, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested, or go to the nearest hospital to find out about the risk and ask for advice on the measures to be taken.
It is recommended to take the package and the package leaflet of the medication to the healthcare professional.
Normally, the symptoms of overdose occur 4 to 6 hours after taking ibuprofen.
Symptoms of overdose may include nausea, stomach pain, vomiting (which may contain bloody sputum), headache, ringing in the ears, confusion, involuntary eye movement, and lack of muscle coordination. At high doses, symptoms of drowsiness, chest pain, palpitations, loss of consciousness, convulsions (mainly in children), weakness, and dizziness, blood in the urine, low potassium levels in the blood, chills, and breathing difficulties have been reported. In rare cases, there have been cases of increased blood plasma acidity (metabolic acidosis), decreased body temperature, altered kidney function, stomach and intestinal bleeding, coma, transient loss of breathing (apnea), central nervous system depression, and respiratory system. There have also been cases of cardiovascular toxicity (decreased blood pressure, decreased heart rate, and increased heart rate).
If a severe overdose occurs, kidney failure and liver damage may occur. In these cases, the doctor will take the necessary measures.
In case of ingestion of significant amounts, activated charcoal should be administered.
If you forget to take Neobrufen
Do not take a double dose to make up for forgotten doses.
If you forget to take your corresponding dose, take it as soon as you remember. However, if the time for the next dose is very close, skip the forgotten dose and take the next dose at the usual time.
Like all medications, this medication can cause adverse effects, although not everyone will experience them.
Adverse effects of medications like Neobrufen are more common in people over 65 years old.
The incidence of adverse effects is lower in short treatments and if the daily dose is below the maximum recommended dose.
Disorientation or confusion, depression, irritability, nervousness, psychotic reaction, vertigo, tinnitus (ringing or sounds in the ear), hearing impairment, reversible toxic amblyopia, liver damage, edema (swelling caused by fluid accumulation in tissues), optic neuritis, anaphylactic reaction (in case of severe generalized hypersensitivity reaction, facial swelling, tongue, and larynx, dyspnea, tachycardia, hypotension, anaphylaxis, angioedema, or severe shock), aseptic meningitis (inflammation of the meninges, which are the membranes that protect the brain and spinal cord, not caused by bacteria). In most cases where aseptic meningitis has been reported with ibuprofen, the patient suffered from some form of autoimmune disease (such as systemic lupus erythematosus and other collagen diseases), which was a risk factor. The symptoms of aseptic meningitis observed were neck stiffness, headache, nausea, vomiting, fever, or disorientation. Other adverse effects are decreased platelets, decreased white blood cells (which may manifest as frequent infections with fever, chills, or sore throat), decreased red blood cells (which may manifest as difficulty breathing and skin pallor), neutropenia (decreased neutrophils), and agranulocytosis (very large decrease in neutrophils), aplastic anemia (bone marrow failure to produce different types of cells), hemolytic anemia (premature destruction of red blood cells). The first symptoms are: fever, sore throat, superficial ulcers in the mouth, pseudogripal symptoms, extreme fatigue, bleeding, and bruising of unknown cause.
Exacerbation of inflammation-related infections has been observed with the use of NSAIDs. If signs of infection or worsening of infection occur during the use of ibuprofen, it is recommended to consult a doctor as soon as possible.
Exacerbation of colitis and Crohn's disease (chronic disease in which the immune system attacks the intestine, causing inflammation that usually produces bloody diarrhea).
A severe skin reaction known as DRESS syndrome (by its English acronym) may occur. The symptoms of DRESS syndrome include: skin rash, lymph node inflammation, and elevated eosinophils (a type of white blood cell).
Generalized red scaly rash, with bumps under the skin and blisters, mainly located in skin folds, trunk, and upper limbs, accompanied by fever at the start of treatment (acute generalized exanthematous pustulosis). Stop taking Neobrufen if you experience these symptoms and seek medical attention immediately. See also section 2.
If any of the following adverse effects occur, discontinue treatment and consult your doctor immediately:
Reporting adverse effects
If you experience any adverse effects, consult your doctor, pharmacist, or nurse, even if it is a possible adverse effect not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es
By reporting adverse effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of sight and reach of children.
Do not use this medication after the expiration date shown on the package after "CAD or EXP". The expiration date is the last day of the month indicated.
Do not store above 25°C.
Medications should not be disposed of through wastewater or household waste. Deposit the packages and medications you no longer need at the SIGRE collection point in the pharmacy. If in doubt, ask your pharmacist how to dispose of packages and medications you no longer need. This will help protect the environment.
Composition of Neobrufen 600 mg effervescent granules
Appearance of the product and package contents
White effervescent granules. Each package contains 40 or 20 sachets.
Marketing authorization holder and manufacturer
Holder:
Viatris Healthcare Limited
Damastown Industrial Park
Mulhuddart, Dublin 15
Dublin
Manufacturer:AbbVie S.R.L., 04011 Campoverde di Aprilia, Latina. Italy.
You can request more information about this medication by contacting the local representative of the marketing authorization holder:
Viatris Pharmaceuticals, S.L.
C/ General Aranaz, 86
28027 Madrid
Spain
This leaflet was revised in January 2024
Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS)
https://www.aemps.gob.es/